Adejoke Aina-Babalola, MD
Internal Medicine · Brentwood, TNNPI 1669556148
Payments from drug & device makers
Across 196 payments — averaging $20.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- AbbVie$332
- Novo Nordisk$299
- AstraZeneca$267
- Lilly USA, LLC$229
- Paratek Pharmaceuticals, Inc.$188
- plus $1K from 35 others
What the payments were for
- Food & beverage$3,961100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 61 | $1,343 |
| AbbVie | 18 | $332 |
| Novo Nordisk | 16 | $299 |
| AstraZeneca | 16 | $267 |
| Lilly USA, LLC | 13 | $229 |
| Paratek Pharmaceuticals, Inc. | 11 | $188 |
| Inspire Medical Systems, Inc. | 1 | $164 |
| Pfizer | 8 | $125 |
| Ironwood Pharmaceuticals, Inc | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $83 |
| Shield Therapeutics Inc | 4 | $65 |
| Abbott | 3 | $62 |
| Kerecis Limited | 3 | $54 |
| Lifenet Health | 2 | $54 |
| Avita Medical Americas, LLC | 1 | $43 |
| Eisai Inc. | 2 | $40 |
| Convatec Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $36 |
| Boston Scientific | 2 | $35 |
| Neuros Medical, Inc. | 1 | $31 |
| Boehringer Ingelheim | 1 | $26 |
| Molnlycke Health Care US, LLC | 1 | $24 |
| Organogenesis Inc. | 1 | $24 |
| Reapplix Inc. | 1 | $23 |
| Solventum Corporation | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Osiris Therapeutics Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| BETA Bionics, Inc. | 1 | $18 |
| Global Blood Therapeutics, Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Optos, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
| Merck | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Exact Sciences | 1 | $14 |
| KCI USA, Inc. | 1 | $13 |
| Insulet Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$164
- GRAFIX PL$115
- Grafix XC$115
- Stravix$115
- STRAVIX PL$115
How this compares
$3,961 in reported general payments places this provider in the 85th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 36 | $54,285 |
| OzempicSemaglutide | 32 | $47,797 |
| FarxigaDapagliflozin Propanediol | 52 | $47,582 |
| RybelsusSemaglutide | 19 | $32,149 |
| CreonLipase/Protease/Amylase | 23 | $24,248 |
| LinzessLinaclotide | 22 | $20,382 |
| EliquisApixaban | 22 | $13,350 |
| JardianceEmpagliflozin | 20 | $12,120 |
| Famotidine | 41 | $3,104 |
| Olmesartan Medoxomil | 40 | $2,296 |
| Lidocaine | 27 | $2,283 |
| Atorvastatin Calcium | 165 | $2,140 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 48 | $1,656 |
| Fluticasone Propionate | 54 | $1,531 |
| Colestipol Hcl | 12 | $1,437 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $299 | $79,94651 claims |
| Lilly USA, LLCMounjaro | $229 | $54,28536 claims |
| AstraZenecaFarxiga | $267 | $47,58252 claims |
| AbbVieCreon, Linzess | $332 | $44,63045 claims |
| PfizerEliquis | $125 | $13,35022 claims |
| Boehringer IngelheimJardiance | $26 | $12,12020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Brentwood
- Mark McKenzieChattanooga$11.9M
- Bernard GrunstraBristol$6.4M
- Jewel WhiteKingsport$5.7M
- Judith WhiteKingsport$5.6M
- Obadias MarquezOoltewah$2.8M
- Amanda Moore MillerKnoxville$2.3M
- Rick WhilesBristol$1.5M
- John AndersonNashville$1.5M
- David MorinKingsport$1.4M
- John KirbyJefferson City$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.